Search

Your search keyword '"Lomustine"' showing total 9 results
Start Over Descriptor "Lomustine" Publication Type Magazines
9 results on '"Lomustine"'

1. Leeds Teaching Hospitals NHS Trust Researcher Furthers Understanding of Glioblastomas (Pcv Vs. Lomustine For Patients With Recurrent Glioblastoma)

Subjects
Care and treatment, Medical personnel training, Hospitals -- United Kingdom, Physical fitness, Vincristine, Lomustine, Chemotherapy, Glioblastomas -- Care and treatment, Medical personnel -- Training, Glioblastoma multiforme -- Care and treatment, Cancer -- Chemotherapy
Abstract

2023 OCT 7 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on glioblastomas is the subject of a new report. According [...]

Published
2023

2. CNS Pharmaceuticals reports over 100 patients enrolled in Berubicin study

Subjects
Medical research, Medicine, Experimental, Lomustine, Business, News, opinion and commentary
Abstract

CNS Pharmaceuticals announced that over 100 patients have been enrolled in the Company's potentially pivotal study with their lead product candidate, Berubicin. The Company has opened 43 clinical trial sites [...]

Published
2023

3. New Medulloblastoma Study Findings Reported from University of Regensburg (Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study)

Subjects
University of Regensburg -- Reports, Care and treatment, Research, Reports, Patient outcomes, Physical fitness -- Research -- Reports, Vincristine -- Research, Medical research -- Reports, Medulloblastoma -- Care and treatment -- Research -- Patient outcomes, Chemotherapy, Obesity, Cancer treatment, Gliomas, Toxicity, Lomustine, Finance, Editors
Abstract

2020 MAY 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Oncology - Medulloblastoma are presented in a new report. [...]

Published
2020

4. Research Findings from Sichuan University Update Understanding of Gliomas (Radiotherapy versus radiotherapy combined with temozolomide in high-risk low-grade gliomas after surgery: study protocol for a randomized controlled clinical trial)

Subjects
World Health Organization, Research, Clinical trials, Gliomas -- Research, Physical fitness, Vincristine -- Research, Chemotherapy, Medical research, Radiotherapy, Medical practice, Cancer treatment, Radiation (Physics), Antineoplastic agents, Operating systems (Software), Public health, Obesity, Physicians, Lomustine, Editors
Abstract

2019 DEC 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on gliomas is now available. According to news originating [...]

Published
2019

5. New Gliomas Findings from Department of Radiation Oncology Reported (Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV)

Subjects
Care and treatment, Research, Reports, Gliomas -- Research -- Care and treatment -- Reports, Physical fitness -- Reports, Vincristine -- Research -- Reports, Chemotherapy -- Reports, Radiotherapy -- Reports, Radiation (Physics) -- Reports, Obesity, Cancer treatment, Cancer, Antineoplastic agents, Lomustine, Editors
Abstract

2019 NOV 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Oncology - Gliomas is now available. According to [...]

Published
2019

6. New Glioblastomas Study Findings Have Been Reported by Investigators at University Hospital [Lomustine-temozolomide Combination Therapy Versus Standard Temozolomide Therapy In Patients With Newly Diagnosed Glioblastoma With Methylated Mgmt ...]

Subjects
Standards, Care and treatment, Medical care quality, Temozolomide -- Standards, Physical fitness, Methylation, Glioblastomas -- Care and treatment, Lomustine, Obesity, Radiotherapy, Antineoplastic agents, Gliomas, Clinical trials, Managers, Editors
Abstract

2019 MAR 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Glioblastomas have been published. According to [...]

Published
2019

7. Study Data from University of Turku Update Knowledge of Melanoma (Long-term Survival of Stage IV Melanoma Patients Treated with BOLD Combination Chemotherapy and Intermediate-dose Subcutaneous Interferon-alpha)

Subjects
Research, Patient outcomes, Care and treatment, Melanoma -- Research -- Patient outcomes -- Care and treatment, Biological response modifiers, Physical fitness, Combination drug therapy, Interferon, Chemotherapy, Obesity, Protein kinases, Cancer metastasis, Lomustine, Therapeutics, Clinical trials, Editors
Abstract

2018 DEC 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Oncology - Melanoma have been presented. According to news [...]

Published
2018

8. Researchers at Institute for Cancer Research and Treatment (IRCCS) Target Glioblastomas (A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent ...)

Subjects
Drug therapy, Cancer treatment, Physical fitness, Cancer -- Drug therapy, Cancer research, Recurrence (Disease) -- Drug therapy, Lomustine
Abstract

2016 OCT 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Oncology - Glioblastomas. According to news reporting [...]

Published
2016

9. NextSource Biotechnology Updates on FDA Short Supply Release of the Formally Known Bristol Myers Squibb (CeeNu) Brand Oncology Product Now Being Marketed under the NextSource Biotechnology Lomustine (CCNU) Exclusively in the U.S

Subjects
United States. Food and Drug Administration, Bristol-Myers Squibb Co., Antineoplastic agents, Pharmaceutical industry, Antimitotic agents, Lomustine, Arts and entertainment industries
Abstract

NextSource BioTechnology (NSB), a specialty pharmaceutical manufacturing and marketing company focused on consolidating, re-branding and launching 'matured & orphan drugs,' has announced its most recent product Lomustine (CCNU), formerly known [...]

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results